Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ümran Toru (Kütahya, Turkey), Ümran Toru, Ceylan Ayada, Osman Genç, Server Sahin, Özlem Arik, Ismet Bulut. Serum levels of RAAS components in COPD. Eur Respir J 2015; 46: Suppl. 59, 3970

Member's Comments

No comment yet.

Related content which might interest you: Serum levels of leptin and visfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Different data in COPD Year: 2015 Increased serum level of apelin in chronic obstructive pulmonary disease Source: International Congress 2015 – COPD: interesting notes Year: 2015 Production of proinflammation cytokines and mean pulmonary arterial pressure in COPD Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 microRNA profile in COPD patients with and without pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH Year: 2015 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Pulmonary hypertension and COPD: Clinical assessment and biomarkers Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Serum angiopoietin-2 levels in stable and exacerbated chronic obstructive pulmonary disease Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 Hypoxia associated with increased systemic concentrations of MPO and NE during exacerbations of COPD Source: International Congress 2015 – New insights into lung disease pathogenesis Year: 2015 Dysregulation of serum miRNA in chronic obstructive pulmonary disease Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015 Pulmonary vessels remodeling in COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 TNF-α, IL-6, IL-10 serum activity in patients with obesity-associated arterial hypertension depend on bronchial obstruction presence Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Can ADMA play a role in determining pulmonary hypertension related to chronic obstructive lung disease? Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease Source: International Congress 2014 – Markers Year: 2014 Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Plasma levels of TIPM-2 in patients with COPD Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Potential association between pulmonary hypertension in COPD and monocyte chemoattractant protein (MCP)-1 Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology Year: 2005